B. Metzler seel. Sohn & Co. AG Acquires 28,435 Shares of UnitedHealth Group Incorporated $UNH

B. Metzler seel. Sohn & Co. AG boosted its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 49.2% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 86,196 shares of the healthcare conglomerate's stock after acquiring an additional 28,435 shares during the period. B. Metzler seel. Sohn & Co. AG's holdings in UnitedHealth Group were worth $35,825,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of the stock. Sarver Vrooman Wealth Advisors bought a new stake in UnitedHealth Group during the 4th quarter valued at approximately $25,000. Anfield Capital Management LLC lifted its stake in shares of UnitedHealth Group by 220.0% in the 4th quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate's stock valued at $26,000 after purchasing an additional 55 shares during the period. Nalls Sherbakoff Group LLC bought a new stake in shares of UnitedHealth Group during the fourth quarter valued at approximately $27,000. Lifetime Wealth Management P.C. bought a new position in UnitedHealth Group in the fourth quarter worth $29,000. Finally, Wilkerson Advisory Group LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at $30,000. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Price Performance

Shares of UNH opened at $399.67 on Thursday. The company has a market capitalization of $358.74 billion, a P/E ratio of 25.72, a price-to-earnings-growth ratio of 1.49 and a beta of 0.61. The firm has a 50 day moving average of $412.56 and a 200 day moving average of $363.18. UnitedHealth Group Incorporated has a twelve month low of $255.96 and a twelve month high of $461.62. The company has a quick ratio of 0.78, a current ratio of 0.78 and a debt-to-equity ratio of 0.66.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $4.94 by $1.44. UnitedHealth Group had a return on equity of 16.53% and a net margin of 3.14%.The firm had revenue of $112.03 billion for the quarter, compared to the consensus estimate of $110.81 billion. During the same period in the prior year, the company posted $4.08 earnings per share. The company's quarterly revenue was up .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. As a group, equities research analysts anticipate that UnitedHealth Group Incorporated will post 19.82 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th will be paid a $2.32 dividend. The ex-dividend date is Monday, September 14th. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.3%. UnitedHealth Group's payout ratio is currently 59.72%.

Insider Buying and Selling at UnitedHealth Group

In related news, CEO Patrick Hugh Conway sold 1,169 shares of the stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $390.00, for a total transaction of $455,910.00. Following the transaction, the chief executive officer owned 15,328 shares in the company, valued at $5,977,920. This represents a 7.09% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.19% of the stock is owned by insiders.

Analyst Ratings Changes

Several brokerages recently issued reports on UNH. Barclays increased their price target on shares of UnitedHealth Group from $429.00 to $441.00 and gave the stock an "overweight" rating in a research note on Monday, July 20th. Leerink Partners raised their target price on shares of UnitedHealth Group from $400.00 to $462.00 and gave the company an "outperform" rating in a research note on Wednesday, June 17th. Piper Sandler set a $477.00 price target on UnitedHealth Group in a research report on Thursday, July 16th. Robert W. Baird raised UnitedHealth Group from an "underperform" rating to a "neutral" rating and raised their price objective for the company from $287.00 to $453.00 in a research report on Thursday, July 16th. Finally, TD Cowen boosted their target price on UnitedHealth Group from $337.00 to $430.00 and gave the stock a "hold" rating in a report on Tuesday, July 14th. Two analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $456.56.

Key UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealthcare plans to eliminate prior-authorization requirements for approximately 1,700 treatments and services, targeting the removal of approval requirements for 30% of healthcare services by year-end. The change could reduce administrative friction for patients and providers while preserving the insurer’s focus on managing medical costs. UnitedHealthcare to drop prior authorization requirements
• Positive Sentiment: Wall Street’s average brokerage recommendation for UnitedHealth remains equivalent to a Buy, indicating that analysts generally view the company’s long-term earnings and business resilience favorably. However, the usefulness of consensus ratings may be limited because sell-side recommendations often skew optimistic. Brokers Suggest Investing in UnitedHealth
• Neutral Sentiment: After gaining 31.8% over the past year, UnitedHealth’s valuation appears neither clearly cheap nor clearly excessive. Investors are weighing the company’s quality and resilience against recent share-price softness and regulatory developments, suggesting that further upside may depend on continued earnings execution. UnitedHealth Stock May Look Reasonable Despite IRS Tax Scrutiny
• Negative Sentiment: IRS tax scrutiny introduces regulatory uncertainty and could weigh on investor confidence, even as the stock’s valuation is viewed as reasonable by some analysts. The issue may limit enthusiasm until its potential financial impact becomes clearer. UnitedHealth Stock May Look Reasonable Despite IRS Tax Scrutiny

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source